• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短链二价依他尼酸酰胺作为谷胱甘肽转移酶 Mu 同工酶的前抑制剂及顺铂耐药卵巢癌的有效增敏剂。

Short divalent ethacrynic amides as pro-inhibitors of glutathione -transferase isozyme Mu and potent sensitisers of cisplatin-resistant ovarian cancers.

机构信息

Key Laboratory of Clinical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.

Department of Pharmacy, University-Town Hospital of Chongqing Medical University, Chongqing, China.

出版信息

J Enzyme Inhib Med Chem. 2022 Dec;37(1):728-742. doi: 10.1080/14756366.2022.2038591.

DOI:10.1080/14756366.2022.2038591
PMID:35176963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865112/
Abstract

The linking of ethacrynic acid with ethylenediamine and 1,4-butanediamine gave EDEA and BDEA, respectively, as membrane-permeable divalent pro-inhibitors of glutathione -transferase (GST). Their divalent glutathione conjugates showed subnanomolar inhibition and divalence-binding to GSTmu (GSTM) (PDB: 5HWL) at ∼0.35 min. In cisplatin-resistant SK-OV-3, COC1, SGC7901 and A549 cells, GSTM activities probed by 15 nM BDEA or EDEA revealed 5-fold and 1.0-fold increases in cisplatin-resistant SK-OV-3 and COC1 cells, respectively, in comparison with the susceptible parental cells. Being tolerable by HEK293 and LO2 cells, BDEA at 0.2 μM sensitised resistant SK-OV-3 and COC1 cells by ∼3- and ∼5-folds, respectively, released cytochrome c and increased apoptosis; EDEA at 1.0 μM sensitised resistant SK-OV-3 and A549 cells by ∼5- and ∼7-fold, respectively. EDEA at 1.7 μg/g sensitised resistant SK-OV-3 cells to cisplatin at 3.3 μg/g in nude mouse xenograft model. BDEA and EDEA are promising leads for probing cellular GSTM and sensitising cisplatin-resistant ovarian cancers.

摘要

乙二醛与乙二胺和 1,4-丁二胺的连接分别得到乙二醛二乙胺(EDEA)和乙二醛二丁胺(BDEA),它们是谷胱甘肽 -S- 转移酶(GST)的膜通透性二价前抑制剂。它们的二价谷胱甘肽缀合物对 GSTmu(GSTM)(PDB:5HWL)表现出亚纳摩尔抑制作用和二价结合,结合常数约为 0.35 min。在顺铂耐药的 SK-OV-3、COC1、SGC7901 和 A549 细胞中,用 15 nM 的 BDEA 或 EDEA 探测 GSTM 活性,与敏感亲本细胞相比,顺铂耐药的 SK-OV-3 和 COC1 细胞分别增加了 5 倍和 1.0 倍。BDEA 在 0.2 μM 时对 HEK293 和 LO2 细胞是耐受的,分别使耐药 SK-OV-3 和 COC1 细胞的敏感性增加了约 3 倍和 5 倍,释放细胞色素 c 并增加细胞凋亡;EDEA 在 1.0 μM 时使耐药 SK-OV-3 和 A549 细胞的敏感性分别增加了约 5 倍和 7 倍。EDEA 在 1.7 μg/g 时使耐药 SK-OV-3 细胞对裸鼠异种移植模型中 3.3 μg/g 的顺铂的敏感性增加。BDEA 和 EDEA 是探测细胞 GSTM 和增敏顺铂耐药卵巢癌的有前途的先导化合物。

相似文献

1
Short divalent ethacrynic amides as pro-inhibitors of glutathione -transferase isozyme Mu and potent sensitisers of cisplatin-resistant ovarian cancers.短链二价依他尼酸酰胺作为谷胱甘肽转移酶 Mu 同工酶的前抑制剂及顺铂耐药卵巢癌的有效增敏剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):728-742. doi: 10.1080/14756366.2022.2038591.
2
Inhibition of the CSF-1 receptor sensitizes ovarian cancer cells to cisplatin.抑制集落刺激因子-1受体可使卵巢癌细胞对顺铂敏感。
Cell Biochem Funct. 2018 Mar;36(2):80-87. doi: 10.1002/cbf.3319. Epub 2018 Jan 25.
3
Glutathione S‑transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.谷胱甘肽 S-转移酶同工酶 alpha 1 主要参与常见实体癌的顺铂耐药性。
Oncol Rep. 2019 Feb;41(2):989-998. doi: 10.3892/or.2018.6861. Epub 2018 Nov 9.
4
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin.对阿霉素、紫杉醇和顺铂耐药的人卵巢癌细胞系中耐药蛋白及相关因子的信使核糖核酸表达
Anticancer Drugs. 1997 Feb;8(2):189-98. doi: 10.1097/00001813-199702000-00010.
5
Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates.改变钌(II)/锇(II)-对异丙基苯共轭物中金属与依他尼酸的比例。
J Inorg Biochem. 2017 Oct;175:198-207. doi: 10.1016/j.jinorgbio.2017.07.027. Epub 2017 Jul 28.
6
A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.一项关于依他尼酸作为人肺癌亲本细胞系和耐药细胞系中美法仑和顺铂敏感性潜在调节剂的研究。
Br J Cancer. 1992 May;65(5):684-90. doi: 10.1038/bjc.1992.145.
7
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.铂(IV)化合物的合理设计以克服谷胱甘肽 - S - 转移酶介导的耐药性。
J Am Chem Soc. 2005 Feb 9;127(5):1382-3. doi: 10.1021/ja0432618.
8
Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate.依他尼酸及其谷胱甘肽共轭物对大鼠和人类谷胱甘肽S-转移酶同工酶的抑制作用。
Biochem Pharmacol. 1990 Oct 1;40(7):1631-5. doi: 10.1016/0006-2952(90)90465-w.
9
Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.通过用埃他卡铂胶束抑制谷胱甘肽 S-转移酶(GSTs)克服顺铂耐药性:在体外和体内的研究。
Biomaterials. 2017 Nov;144:119-129. doi: 10.1016/j.biomaterials.2017.08.021. Epub 2017 Aug 17.
10
Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.新型加巴辛类似物对谷胱甘肽 S-转移酶 M1 的抑制作用对于克服肺癌细胞对顺铂的耐药性至关重要。
J Med Chem. 2011 Dec 22;54(24):8574-81. doi: 10.1021/jm201131n. Epub 2011 Nov 23.

引用本文的文献

1
Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications.谷胱甘肽S-转移酶在人类疾病中的过表达:药物靶点与治疗意义
Antioxidants (Basel). 2023 Nov 6;12(11):1970. doi: 10.3390/antiox12111970.
2
GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients.GRP75 介导的线粒体相关内质网膜(MAM)完整性控制卵巢癌患者对顺铂的耐药性。
Int J Biol Sci. 2022 Apr 11;18(7):2914-2931. doi: 10.7150/ijbs.71571. eCollection 2022.

本文引用的文献

1
Glutathione S-Transferases in Cancer.癌症中的谷胱甘肽S-转移酶
Antioxidants (Basel). 2021 Apr 29;10(5):701. doi: 10.3390/antiox10050701.
2
The mercapturic acid pathway.巯基尿酸途径。
Crit Rev Toxicol. 2019 Nov;49(10):819-929. doi: 10.1080/10408444.2019.1692191. Epub 2020 Jan 16.
3
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1.谷胱甘肽转移酶 P1-1 介导的顺铂耐药的基于结构的机制。
Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):13943-13951. doi: 10.1073/pnas.1903297116. Epub 2019 Jun 20.
4
Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors.谷胱甘肽转移酶:克服实体瘤化疗耐药性的潜在靶点。
Int J Mol Sci. 2018 Nov 28;19(12):3785. doi: 10.3390/ijms19123785.
5
Glutathione S‑transferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.谷胱甘肽 S-转移酶同工酶 alpha 1 主要参与常见实体癌的顺铂耐药性。
Oncol Rep. 2019 Feb;41(2):989-998. doi: 10.3892/or.2018.6861. Epub 2018 Nov 9.
6
The multifaceted role of glutathione S-transferases in cancer.谷胱甘肽 S-转移酶在癌症中的多效作用。
Cancer Lett. 2018 Oct 1;433:33-42. doi: 10.1016/j.canlet.2018.06.028. Epub 2018 Jun 27.
7
Drug metabolizing enzymes and their inhibitors' role in cancer resistance.药物代谢酶及其抑制剂在癌症耐药中的作用。
Biomed Pharmacother. 2018 Sep;105:53-65. doi: 10.1016/j.biopha.2018.05.117. Epub 2018 May 26.
8
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.生物系统中的多价相互作用:对多价配体和抑制剂设计与应用的启示
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
9
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.谷胱甘肽转移酶:癌症和神经退行性疾病中的底物、抑制剂及前药
Oncogenesis. 2018 Jan 24;7(1):8. doi: 10.1038/s41389-017-0025-3.
10
Activity-Based Probes for Isoenzyme- and Site-Specific Functional Characterization of Glutathione S-Transferases.基于活性的谷胱甘肽S-转移酶同工酶和位点特异性功能表征探针
J Am Chem Soc. 2017 Nov 15;139(45):16032-16035. doi: 10.1021/jacs.7b07378. Epub 2017 Nov 1.